Fingerprint
Dive into the research topics of 'A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma
T. E. Witzig, C. B. Reeder, B. R. Laplant, M. Gupta, P. B. Johnston, I. N. Micallef, L. F. Porrata, S. M. Ansell, J. P. Colgan, E. D. Jacobsen, I. M. Ghobrial, T. M. Habermann
Research output: Contribution to journal › Article › peer-review
253
Scopus
citations